Shareholding disclosure
Prinz Michael von Liechtenstein
Declared position
47.71%
Threshold
Crossed upwards
Timeline
Published
16.10.2012
Transaction
11.10.2012
Transfer date
18.10.2012
Voting rights breakdown
Voting rights acquired47.71%
Voting rights sold43.53%
Below threshold0%
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
TBCAF00032
Beneficial owner
Prinz Michael von Liechtenstein
Declared address
Prinz Michael von Liechtenstein, 9490 Vaduz
Dute to the purchase agreement dated 27th June 2012, Biopharma Invest AG has sold no. 2'250'000 ordinary shares of mondoBIOTECH holding AG. By doing so, its participation is reduced to a total of no. 32'876'675 shares, representing 47.71% of the total share capital of the Company.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open